Audit in practice : surveillance for hypoglycaemia in the neonatal paediatric intensive care unit by Grech, Victor E. & Soler, Paul
l 
Maltese Medical Journal. 1998; 10(2): 30 
All rights reserved 
Audit in Practice: 

Surveillance for hypoglycaemia in the 

Neonatal Paediatric Intensive Care Unit 

Victor Grech*, Paul Soler* 
ABSTRACT: Hypoglycaemia in neonates is defined as a blood glucose::::; 2.6 mmol/1. Certain 
categories of babies are at particularly high risk of developing hypoglycaemia in the first few days 
of life, and are routinely monitored in the Neonatal Paediatric Intensive Care Unit by reagent strips 
using a reflectance meter. This study shows that the current glucose meter, in use in the entire 
Department of Health, is unreliable in the detection of hypoglycaemia in neonates, but is accurate 
for values of blood glucose >3 mmol/1. For thisreason, laboratory blood glucose estimation should 
be used for screening of neonatal hypoglycaemia until such time that a more reliable technique for 
bedside assay of blood glucose becomes available in the Neonatal Paediatric Intensive Care Unit. 
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Introduction 
Glucose is an essential metabolite that is used 
throughout the body as an energy source. After delivery. 
the normal · baby must adapt from a continuous 
transplacental supply of glucose. to an intermittent 
enteral source of milk . The usual sequence of events at 
birth is a fall in blood glucose. followed by a rise in 
circulating glucagon and adrenaline. mobilisation of fat 
from peripheral stores. and production of glucose from 
the breakdown of hepatic glycogen ' . 
Hypoglycaemia in the neonatal age group is defined as 
a blood glucose level 2.6 mmol/l 2. Risk factors for the 
development of hypoglycaemia include prematurity. 
infants born small for gestational age (defined as weight 
10th centile). infants of diabetic mothers. birth asphyxia. 
starvation. sepsis. cold injury. congenital heart disease. 
rhesus incompatibility. and maternal treatment including 
glucose infusions and drugs (e .g. -agonists used to delay 
labour in premature infants»). 
Hypoglycaemia and its deleterious effects in the full 
tenn and premature neonate have been recognised since 
19114. The brain consumes glucose at a high rate 
compared to other organs. The neonatal brain comprises 
12% of the body's total mass. when compared to 2% for 
an adult. Hence, the typical rate of glucose production in 
a neonate of 4-6 mg/kg/minute is far higher than in an 
adultS. Short-term effects include central nervous system 
dysfunction which has been demonstrated by impaired 
auditory brain stcm and somatosensory evoked potcntials 
in infants at blood glucose levels ::::; 2.6 mmol/l 6. 
Prolongcd and/or severe hypoglycaemia may result in 
long-term morbidity including mental retardation, 
delayed developmcnt and ccrebral palsy 7.8. 
Hypoglycaemia in neonates may be symptomatic or 
asymptomatic9 • thcrefore monitoring of blood glucose 
levels is essential for the detection and treatment of 
asymptomatic hypoglycaemia in high-risk nconates. 
Traditionally. glucose monitoring in high risk neonates 
in Malta was carried out with reagent strips using a 
reflectance meter, generically known locally as 
dextrostix or DXT. This provides a quick and cheap 
screening test when COol pared to laboratory estimation 
of blood glucose. In accordance with unit policy, in the 
event of a DXT ::::; 2.6 mmol/1, low blood glucose levels 
are confirnled by a laboratory ' sample and appropriate 
treatment instituted. Treatment varies according to the 
severity and duration of hypoglycaemia. and escalates 
from a simple milk feed. to a bolus dose of glucagon. to 
a bolus of dextrose solution followed by an intravenous 
infusion. which may need to have a high concentration 
of glucose and may therefore require central access4 . 
It is. recognised that monitoring of blood glucose by 
various reagent strip methods is inaccurate at lower 
levels of glucose. and inaccuracy is compounded by a 
high haematocrit, and varying ambient temperatures at 
which meters are operated 10. 
The aim of this study was to assess the new bedside 
monitoring system (Medisense) that was recently 
introduced for the entire Health Division in Malta versus 
laboratory estimation of blood glucose in patients 
admitted to Neonatal Paediatric Intensive Care Unit 
(NPICU). 
Methods 
Laboratory estimation of blood glucose (Hitachi 912: 
glucose oxidase GOD-PAP) was taken as the control. 
Hypoglycemia was defined as blood glucose 2.6 mmol/ 
I. It is the policy for all newly admitted patients to the 
NPICU to undergo routine reagent strip glucose 
estimation . Infants at high risk are also monitored for the 
first few day/s of life. For the duration of the study 
period (20/06/98-05/08/98). blood was taken for 
simultaneous bedside and laboratory glucose estimation. 
Care was taken to obtain a full drop of blood onto 
reagent strips as recommended by the strip manufacturer 
while free flowing blood (arterial or venous) was be ing 
taken for laboratory glucose estimation. 
Sensitivity. specificity. positive predictive values and 
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Table 1: Sensitivity, specificity, positive predictive values and 
negative predictive values for Medisense 
(20/06/98-05/08/98 
Hypoglycemia 
Present Absent 
DXTI Positive 10 9 
Negative 6 34 
Results 
Sensitivity 62.5% 
Specificity 79.1 % 
Positive 
predictive value 52.6% 
Negative 
predictive value 85 .0% 
negative predictive values were calculated 11 . In this 
setting, sensitivity of DXT was defined as how many 
hypoglycemic patients were simultaneously found to 
sensitive and 
glucose 12. It 
required for 
specific in the low range of blood 
is likely that such a meter will only be 
NPICU use. and that it would be cost­
effective since the number of samples of blood sent for 
formal laboratory assay would drastically diminish. 
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Table 2: Results of correlation and linear regression analysis between 
RBG and DXT (Medisense) 
Correlation analysis 
For values of RBG n Kendall's L P 
::5 3 mmollI 23 0.04 0.79 
> 3 mmol/I 36 0.56 <0.0001 
have a low DXT. Specificity of DXT was defined as 
how many of those without hypoglycaemia had a DXT 
within the normal range. Positive predictive value was 
defined as how many of those with a DXT showing 
hypoglycaemia were really hypoglycaemic. Negative 
predictive value was defined as how many of those with 
a normal DXT were really not hypoglycaemic. Linear 
regression analysis was performed and Kendall's L was 
used for correlations. A p value ::5 0.05 was taken to 
represent a statistically significant result. 
Results 
Sensitivity. specificity. positive predictive values and 
negative predictive values for the detection of 
hypoglycaemia using Medisense are shown in Table I. 
Poor values were obtained for all four measures. 
Results of correlation and linear regression analysis 
are shown in Table 2. nlere is a close agreement 
between RBG and DXT for values of RBG >3 mmol/l. 
but a poor correlation for values of RBG ::5 3 mnlOl/l. 
Discussion 
The new meter (Medisense) is clearly unsatisfactory 
for the detection of hypoglycaemia in neonates. and 
hypoglycaemia may be missed. or treatment for 
hypoglycaemia may be inappropriately instituted. 
The lack of sensitivity. specificity. poor/low. positive 
and negative predictive values for glucose meters is 
attributed to the fact that conventional DXT 1ll~lchinc s 
are designed to detect hyperglycaemia in older paticllts. 
The glucose monitoring policy in NPICU has changed as 
a result of this study, such that DXTs are not pcrformcd 
and assessment of blood glucose is carried out on a 
formal laboratory blood sample. 
If the policy of using bedside estimation of blood 
glucose in NPICU is to be re-institutcd. consideration 
should be given to the purchase of a mcter which is 
Linear regression analysis 
Intercept r t statistic p 
2.12 0 .08 0.22 0.83 
-0.08 1.04 20.60 <0.000 I 
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1
Drs. Grech and Sol er, in their article on routine 
surveillance of hypoglycaemia in newboms, have raised 
a number of important issues. Firstly, they have 
confirmed the problems with the use of stick tests based ",·
r· 
on reflectence monitoring in this cohort of patients. 
Secondly, they have highlighted the importance of in­
house auditing of medical procedures and, by doing so, 
have confirmed the inaccuracy of a (previously) standard 
mode of glucose measurement, with potential dire 
r 
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consequences to the patient. Finally, as a result of this 
audit, appropriate measures have been taken to correct 
the problem. Indeed, the use of glucose-stix monitors 
was discontinued on the NPICU and a formal request for 
a non-stick based monitor suitable for the neonatal age 
group made. One such glucose monitor which uses a 
micro-cuvette for blood sampling has now been procured 
and is in use on the NPICU. Preliminary paired 
sampling with whole blood laboratory measurements 
have shown a close correlation. This will eliminate 
further problems with unreliable glucose results, 
improve the standard and safety of neonatal care, and 
provide a cost benefit by considerably restricting the 
need for laboratory glucose measurements. 
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